Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: A population-based study

American Journal of Kidney Diseases

Volumn 57, Issue 6, 2011, Pages 856-862

  Patch, Christine ^a   Charlton, Judith ^b   Roderick, Paul J ^c   Gulliford, Martin C ^b  

^a and University of Bristol   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

antihypertensive drugs; hypertension; mortality; Polycystic kidney, autosomal dominant; survival

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POISSON DISTRIBUTION; POPULATION RESEARCH; PRESCRIPTION; RENAL REPLACEMENT THERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYPERTENSION, RENAL; INCIDENCE; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79956349427     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.01.023     Document Type: Article

References (25)

1. C. Byrne, D. Ford, J. Gilg, D. Ansell, and J. Feehally UK ESRD incident rates in 2008: national and centre-specific analyses UK Renal Registry The Twelfth Annual Report 2009 2009 UK Renal Registry London http://www.renalreg. com/Reports/2009.html Accessed August 28, 2010
2. C.G. Iglesias, V.E. Torres, K.P. Offord, K.E. Holley, C.M. Beard, and L.T. Kurland Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980 Am J Kidney Dis 2 6 1983 630 639 (Pubitemid 13078640)
3. M. Taylor, A.M. Johnson, M. Tison, P. Fain, and R.W. Schrier Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications Am J Kidney Dis 46 3 2005 415 423 (Pubitemid 41208176)
4. G.M. Fick, A.M. Johnson, W.S. Hammond, and P.A. Gabow Causes of death in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 12 1995 2048 2056
5. A.B. Chapman, K. Stepniakowski, and F. Rahbari-Oskoui Hypertension in autosomal dominant polycystic kidney disease Adv Chronic Kidney Dis 17 2 2010 153 163
6. R.D. Perrone, and D.C. Miskulin Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen? Am J Kidney Dis 46 3 2005 557 559 (Pubitemid 41208193)
7. A.B. Chapman, V.E. Torres, and R.D. Perrone The HALT polycystic kidney disease trials: design and implementation Clin J Am Soc Nephrol 5 1 2010 102 109
8. T. Ecder, C.L. Edelstein, and G.M. Fick-Brosnahan Progress in blood pressure control in autosomal dominant polycystic kidney disease Am J Kidney Dis 36 2 2000 266 271 (Pubitemid 30485834)
9. R.W. Schrier, K.K. McFann, and A.M. Johnson Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease Kidney Int 63 2 2003 678 685 (Pubitemid 36126815)
10. Office for National Statistics Key Health Statistics From General Practice 1998 Series MB6 No 2 London, UK: Office for National Statistics http://www.statistics.gov.uk/downloads/theme-health/key-Health-Stats-1998.pdf Accessed July 23, 2010
11. N.F. Khan, S.E. Harrison, and P.W. Rose Validity of diagnostic coding within the General Practice Research Database: a systematic review Br J Gen Pract 60 572 2010 e128 e136
12. E. Herrett, S.L. Thomas, and W.M. Schoonen Validation and validity of diagnoses in the General Practice Research Database: a systematic review Br J Clin Pharmacol 69 1 2010 4 14
13. M.J. Brown, J.K. Cruickshank, A.F. Dominiczak Executive Committee, British Hypertension Society Better blood pressure control: how to combine drugs J Hum Hypertens 17 2 2003 81 86 (Pubitemid 36292361)
14. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Washington DC: US Department of Health and Human Services, National Institutes of Health http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full. pdf Accessed August 28, 2010
15. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 suppl 2 2002 S1 S246
16. B. Williams, N.R. Poulter, M.J. Brown BHS Guidelines Working Party British Hypertension Society Guidelines for Hypertension Management, 2004-BHS IV: summary BMJ 328 7440 2004 634 640 (Pubitemid 38340037)
17. T. Doran, C. Fullwood, and H. Gravelle Pay-for-performance programs in family practices in the United Kingdom N Engl J Med 355 4 2006 375 384 (Pubitemid 44127540)
18. M.C. Gulliford, J. Charlton, and R. Latinovic Trends in anti-hypertensive and lipid lowering therapy in type 2 diabetes: clinical effectiveness or clinical discretion? J Hum Hypertens 19 2005 111 117 (Pubitemid 40220633)
19. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665 10.1136/bmj.b1665
20. D.S. Wald, M. Law, J.K. Morris, J.P. Bestwick, and N.J. Wald Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials Am J Med 122 3 2009 290 300
21. G.L. Bakris Slowing nephropathy progression: focus on proteinuria reduction Clin J Am Soc Nephrol 3 suppl 1 2008 S3 S10
22. T. Ecder, C.L. Edelstein, and G.M. Fick-Brosnahan Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease Am J Nephrol 21 2 2001 98 103 (Pubitemid 32453687)
23. R. Zeltner, R. Poliak, B. Stiasny, R.E. Schmieder, and B.D. Schulze Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease Nephrol Dial Transplant 23 2 2008 573 579 (Pubitemid 351767642)
24. T. Ecder, C.L. Edelstein, and A.B. Chapman Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease Nephrol Dial Transplant 14 5 1999 1113 1116 (Pubitemid 29209293)
25. T. Ecder, A.B. Chapman, G.M. Brosnahan, C.L. Edelstein, A.M. Johnson, and R.W. Schrier Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease Am J Kidney Dis 35 3 2000 427 432